Trial Profile
The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms SEATIS
- 27 Mar 2020 Status changed from recruiting to completed.
- 05 Jun 2015 New trial record